Register Now: Does Your Pharmaceutical WMS Grow with You?
News|Articles|November 13, 2024

Pharma Pulse 11/13/24: Strategies for Bridging the Sponsor-Site Tech Divide, Innovative Approaches to Chronic Disease Management & more

The latest news for pharma industry insiders.

As health care evolves, innovative strategies continue to emerge to address chronic conditions, enhance medication access, and manage operational challenges in pharmacy settings. Heart failure (HF), diabetes, and performance-based reimbursement models each present unique complexities in care delivery and financial sustainability.

European Stocks Drop Most in Three Months as Trump Worries Mount

European stocks dropped the most in over three months, amid worries that President-elect Donald Trump’s policies will stoke inflation and that his plans to increase tariffs could hit growth in the region.

48% of Americans Have Been Unable to Fill a Needed Prescription Due to Cost

Navitus Health Solutions revealing that 48% reported that the price of medication had affected their ability to get a medicine they needed at least once. The survey looked at consumer attitudes around drug pricing and awareness around issues impacting pricing. Notably, 88% believe prescription drug pricing should be a priority for the next administration following the election.

E.B. Butt on LinkedIn

#coldchainsolutions # AI # riskmanagement # sustainability # logisticsstrategies # keeppharmamoving

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs


Related to this article

CVS Pharmacy Sign at Storefront Entrance | © Mark Roger Bailey - stock.adobe.com 557616813
In this week’s Pharma Pulse, CVS Health plans to separate into two public companies, Bayer weighs what MFN pricing could mean for its launch strategies and an ACTO survey finds most life sciences leaders see no clear industry standard for responsible AI.